Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.
about
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases.Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions.Update on the use of defibrotide.Translational research efforts in biomarkers and biology of early transplant-related complications.Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasiasDefibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malariaCounting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romanceSafety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.Pharmacokinetic profile of defibrotide in patients with renal impairment.Insights into defibrotide: an updated review.Use of defibrotide in the treatment and prevention of veno-occlusive disease.Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan.Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.Mesenchymal Stromal Cells Protect Endothelial Cells from Cytotoxic T Lymphocyte-Induced Lysis.FDA-Approved Oligonucleotide Therapies in 2017.Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cells.Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity.Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide DrugsProgrammed hepatocytes cell death associated with FLIP downregulation in response to extracellular preS1/2.Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome.Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.Raiders of the lost mark - endothelial cells and their role in transplantation for hematologic malignancies.
P2860
Q33256286-638CD560-606F-4142-8311-BE78D097D5BBQ33364848-BDE4CA01-EC9E-4D13-8FA4-09CE088DDD58Q34207695-711B0005-EA3D-4AA6-A59B-A038B94C556EQ34445293-EF716DE7-BFFE-4BAE-B5C0-0B9C8C341805Q34583004-2B5F42FE-B53F-405B-A51E-DA5AB2146E9BQ34635449-16404921-6A40-4C3B-8D37-B48F1EDF89FFQ35185329-A46096B2-34BF-4A4C-91D2-085F304D3546Q35462258-B85647F6-5B89-4D03-9243-6448E03709EDQ35782993-7DB7FA17-53FE-40EE-910E-1EAEF6E1E568Q35934133-B72F4B76-1D3D-48C5-939B-F8C6A760AEACQ36447619-8EF60A5E-4DEB-4557-A9FE-1AB823E2830FQ36755496-5554E72B-6B4D-4345-A2DD-A992C37CA2EAQ36768621-8523F796-461A-4029-B549-A5C9E73C55E0Q36997723-DCF47EDC-AF13-42E6-9F96-50E9CF1D491AQ37112632-19C451BB-6B0D-4B7F-8CDB-E145CE1F30DCQ37194132-C35C7475-DDA5-4A36-9256-7BF7602E3AE5Q37489891-3C62FB64-E4D3-49CB-9574-577CD1568884Q37810075-6A33997D-12ED-4AEA-A125-0CF91078B0F4Q38060264-1B129135-BC2B-4F25-BA49-E92ABB442621Q38616218-C1132B45-BCAD-426A-8963-18BAB56D8B70Q38759497-642BC477-83A4-45D1-A158-85826D484F95Q39214058-7F17180F-3F14-4476-B462-490105A3691BQ39511703-15BF19E9-EB92-47C5-81DB-01DE43EBD539Q40398654-AAD75398-81CA-4BD4-A21F-0EA0EBFDD05BQ40444921-E17A7647-31F7-4C34-96FC-839F5C87A675Q41093104-C4199B67-4711-43E3-9466-9417424660C0Q42254676-9F542625-51BA-42CD-9CE6-AD37976E9E7CQ45067466-EBC4F399-D844-4B82-929A-820902FA84C5Q46846856-A3204BD6-E2B3-4A16-A8FD-CB5145494F4CQ50189731-35D3E1B7-5F32-49F3-8962-A49B307C5FE8Q51651776-3C2E78AF-14A0-469B-B554-2435F3AE5257
P2860
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@en
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@nl
type
label
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@en
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@nl
prefLabel
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@en
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@nl
P2093
P356
P1433
P1476
Fludarabine induces apoptosis, ...... tective effect of defibrotide.
@en
P2093
Armin Gerbitz
Daniela Sondermann
Ernst Holler
Gabriele Multhoff
Günther Eissner
Reinhard Andreesen
Silvia Haffner
Silvia Kirchner
Sonja Bauer
P304
P356
10.1182/BLOOD.V100.1.334
P407
P577
2002-07-01T00:00:00Z